Cargando…
Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285188/ https://www.ncbi.nlm.nih.gov/pubmed/35838892 http://dx.doi.org/10.1007/s12350-022-03059-5 |
| _version_ | 1784747718717997056 |
|---|---|
| author | Miller, Edward J. Campisi, Roxana Shah, Nishant R. McMahon, Sean Cuddy, Sarah Gallegos-Kattan, Cesia Maurer, Mathew S. Damy, Thibaud Slart, Riemer H. J. A. Bhatia, Ketan Einstein, Andrew J. |
| author_facet | Miller, Edward J. Campisi, Roxana Shah, Nishant R. McMahon, Sean Cuddy, Sarah Gallegos-Kattan, Cesia Maurer, Mathew S. Damy, Thibaud Slart, Riemer H. J. A. Bhatia, Ketan Einstein, Andrew J. |
| author_sort | Miller, Edward J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9285188 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92851882022-07-15 Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement Miller, Edward J. Campisi, Roxana Shah, Nishant R. McMahon, Sean Cuddy, Sarah Gallegos-Kattan, Cesia Maurer, Mathew S. Damy, Thibaud Slart, Riemer H. J. A. Bhatia, Ketan Einstein, Andrew J. J Nucl Cardiol Information Statement Springer International Publishing 2022-07-15 2022 /pmc/articles/PMC9285188/ /pubmed/35838892 http://dx.doi.org/10.1007/s12350-022-03059-5 Text en © The Author(s) under exclusive licence to American Society of Nuclear Cardiology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Information Statement Miller, Edward J. Campisi, Roxana Shah, Nishant R. McMahon, Sean Cuddy, Sarah Gallegos-Kattan, Cesia Maurer, Mathew S. Damy, Thibaud Slart, Riemer H. J. A. Bhatia, Ketan Einstein, Andrew J. Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title | Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title_full | Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title_fullStr | Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title_full_unstemmed | Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title_short | Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement |
| title_sort | radiopharmaceutical supply disruptions and the use of (99m)tc-hydroxymethylene diphosphonate as an alternative to (99m)tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: an asnc information statement |
| topic | Information Statement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285188/ https://www.ncbi.nlm.nih.gov/pubmed/35838892 http://dx.doi.org/10.1007/s12350-022-03059-5 |
| work_keys_str_mv | AT milleredwardj radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT campisiroxana radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT shahnishantr radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT mcmahonsean radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT cuddysarah radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT gallegoskattancesia radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT maurermathews radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT damythibaud radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT slartriemerhja radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT bhatiaketan radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement AT einsteinandrewj radiopharmaceuticalsupplydisruptionsandtheuseof99mtchydroxymethylenediphosphonateasanalternativeto99mtcpyrophosphateforthediagnosisoftransthyretincardiacamyloidosisanasncinformationstatement |